‘NanoPass’ Closes Funding for Microneedle Technology

NanoPass Technologies, a developer of painless skin delivery solutions for vaccines and large molecules , announced it has recently closed a new round of financing, led by Israel HealthCare Ventures (IHCV), a healthcare-dedicated venture capital fund, with the participation of existing investors. The capital raised will be used to accelerate the market penetration of NanoPass’ applications through additional licenses with pharmaceutical companies. NanoPass is based in Nes Ziona, Israel.